peptide
ARA-290 (cibinetide) tracker
Educational reference for ARA-290 (cibinetide). Use it inside TrackPep to log doses, side effects, and rotation sites.
Half-life
—
Tmax
—
Category
peptide
Also known as: cibinetide
ARA-290 is an investigational erythropoietin-derived peptide.
Mechanism
An 11-amino-acid peptide derived from erythropoietin that targets the innate repair receptor without stimulating red-cell production.
Research summary
Studied in small phase 2 trials for neuropathic pain and sarcoidosis-related small-fibre neuropathy. Not FDA-approved.
Educational summary of published research. Not dosing guidance or medical advice.
Sources
- ARA 290 phase 2 trials · peer-reviewed clinical trialsHuman half-life was not verified for this entry; none shown.
TrackPep on seurantasovellus. Se tallentaa tekemäsi kirjaukset eikä koskaan suosittele tai laske määriä.